Literature DB >> 25976961

Pearls and pitfalls in factor inhibitor assays.

D M Adcock1, E J Favaloro2.   

Abstract

The proper performance and interpretation of factor inhibitor assays is a critical role for the hemostasis laboratory. Both false-positive and false-negative inhibitor assays may be reported, leading to serious patient mismanagement. Knowledge and recognition of common causes of both false-positive and negative-results can aid in the identification of these potential pitfalls. Safeguards to reporting accurate factor inhibitor assays include initial characterization of the sample, using the Nijmegen modification, properly performing and interpreting an incubated mixing test in conjunction, and performing two dilutions for each dependent dilution in the factor inhibitor assay.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  EDTA; Factor inhibitor assay; factor VIII inhibitor; false negative; false positive; lupus anticoagulant

Mesh:

Substances:

Year:  2015        PMID: 25976961     DOI: 10.1111/ijlh.12352

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  4 in total

Review 1.  Experience of Immune Tolerance Induction Therapy for Hemophilia A Patients with Inhibitors from a Single Center in India.

Authors:  Tulika Seth
Journal:  Indian J Hematol Blood Transfus       Date:  2019-11-04       Impact factor: 0.900

2.  Predictors of the outcome of immune tolerance induction in patients with haemophilia A and inhibitors: The Brazilian Immune Tolerance (BrazIT) Study protocol.

Authors:  Ricardo Mesquita Camelo; Daniel Gonçalves Chaves; Luciana Werneck Zuccherato; Suely Meireles Rezende
Journal:  PLoS One       Date:  2021-08-26       Impact factor: 3.240

3.  Could a Haematoma Be Due to an Acquired Phenomenon?

Authors:  Mansoor Zafar; William Butler-Manuel; Joel Newman; Stefano Berliti; Anna Cowley
Journal:  Cureus       Date:  2021-11-21

4.  Concomitant factor VIII inhibitor and lupus anticoagulant in an asymptomatic patient.

Authors:  Jeremy W Jacobs; Savanah D Gisriel; Krishna Iyer; Henry M Rinder
Journal:  J Thromb Thrombolysis       Date:  2021-10-25       Impact factor: 2.300

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.